Minerva Surgical Inc. (NASDAQ:UTRS) currently has a daily average trading volume of 151.38K but it saw 368814 shares traded on Wednesday. With a market cap of 4.90M USD, stock’s current market price of $0.18 came falling about -5.95 while comparing to the previous closing price of $0.19. In past 52 weeks, the stock remained buoying in the range of price level as high as $7.59 and as low as $0.18. In the recent trading on the day, stock has struck highest price mark of $0.1984 while lowest mark touched by it was $0.1614.
Taking a look at 20-day trading activity of Minerva Surgical Inc. (UTRS) gives us an average price of $0.2982, while its current price level is -97.65% below from 52-week high level whereas it is -1.44% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.5364 while that of 200 days or SMA-200 reads an average of $2.4942. A closer look into the stock’s movement over the week reveals that its volatility is standing at 20.86% during that period while stretching the period over a month that increases to 21.47%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 19.04 which implies that the stock is in oversold territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the UBS which initiated the stock as “Buy” in its note to investors issued on November 16, 2021, recommending a price target of $15 for it. Piper Sandler also issued its recommendations for the stock as it initiated the price target for the stock is $17.
Over the week, UTRS’s stock price is moving -17.93% down while it is -51.77% when we observe its performance for the past one month. Year-to-date it is -96.53% down and over the past year, the stock is showing a downside performance of -97.46%.
The latest quarterly earnings report issued by the company was for quarter ended 6/29/2022, when its quarterly earnings per share (EPS) of -$0.2 beat the consensus estimate of -$0.34 for the same. For UTRS, analysts are forecasting an EPS-growth rate of 79.00% for current year and estimate for EPS growth in next year is 6.10%. In next quarter, company is expected to be making quarterly sales of $15.9 million as analysts are expecting the sales for current fiscal year at $50.85 million and seeing the company making $57.05 million in sales next year. Moreover, analysts are in estimates of $12.6 million for current-quarter revenue.
Currently, Minerva Surgical Inc.’s total number of outstanding shares is 28.55M with 7.36% of that held by the insiders while 77.38% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -56.90%. Stock has a price to book (P/B) ratio of 0.17 while price to sale or P/S ratio amounts to 0.10.
As per SEC documents, Vanguard Total Stock Market Index shunned 355,599 of company’s common stock of worth $0.14 million as per recent closing price of the stock. Vanguard Total Stock Market Index is not the only institutional holder which restructured its stake in Minerva Surgical Inc., as Fidelity Small Cap Growth Fund dumped 312,923 shares of worth $0.12 million to bring its holdings to a total of -0.22 million shares.